Biotech Soars 94% on New Drug Data 🚀

Biotech is leading today's premarket gainers. Get a full report on all 4 top stocks inside [Image](www.elitetrade.club) Good Morning! Hey, guys and gals. It's Chris from Elite Trade Club, here to give you the day's premarket trading news. Today is Tuesday, September 13th. Let's get ready to trade! Markets 📈 The Dow added 0.7% on Monday, while the S&P 500 advanced 1.1%. The Nasdaq rallied 1.3% on the trading session, and the Russell 2K jumped 1.2%. Today, futures are in the green ahead of the opening bell. S&P 500 contracts are up 0.6%. Sponsored [Ultra-Wealthy Rancher Says “Wake up America”]( He’s one of the most successful businessmen in America over the past 50 years… And today, he’s coming forward with an urgent warning for Americans. [Get the full details here.]( Premarket Highlights 🔎 - US Banks lost a record $370 billion in deposit outflows last quarter, and some experts believe the Fed's rate-hiking policy is to blame. - Twitter shareholders poised to approve Elon Musk takeover deal by a wide margin, according to a Wall Street Journal exclusive. What to Watch Today 👀 Inflation Data Today's Core CPI report could have a major impact on investor sentiment in today's trading session. Economists expect year-over-year CPI to cool 8.0% after coming in at 8.5% last month. However, many experts are still doubtful that inflation has hit its peak. Today, we'll find out if last month's cooling inflation number was an anomaly or the beginning of a trend. International 🌍 Asia India's BSE Sensex gained 0.8% overnight, while the Australian ASX 200 added 0.7%. Japan's Nikkei 225 advanced 0.3%. Europe Germany's DAX is up 0.7%, and the French CAC 40 is showing a 0.6% gain. The Euro Stoxx 600 has risen 0.4% on the trading session. Major Earnings 💰 Core & Main [CNM] ... AM InnovAge [INNV] ... PM Bespoke Capital Acquisition [VWE] ... PM Iris Energy [IREN] ... PM Evolution Petroleum [EPM] ... PM Connect Biopharma Holdings [CNTB] ... PM Aspen Group [ASPU] ... PM Economy 🏗 - NFIB small-business index [Aug] ... 6a Consumer price index [Aug] ... 8:30a Federal budget [Aug] ... 2p Running Hot 🔥 Gainers - Tyme Tech [TYME] >> +20.4% - American Rebel Holdings [AREB] >> +25.5% - Salarius Pharmaceuticals [SLRX] >> +24.9% Decliners - Rent the Runway [RENT] >> (24.3%) - Rubius Therapeutics [RUBY] >> (15.8%) - Cardiff Oncology [CRDF] >> (19.0%) NortonLifeLock [NLOK] - Last Close: $22.75 NortonLifeLock is up after closing on a key acquisition. The consumer cybersecurity company announced yesterday that it had completed its previously-announced acquisition of UK antivirus software firm Avast. Shares of Avast will be delisted from the London Stock Exchange today, according to a company statement. The combined company will continue trading under NLOK unless a new name and/or ticker symbol is announced. NLOK is leading the S&P 500 with a 4.4% gain. My Take: Nothing very exciting to see here. Today's small rally might be all you get from this catalyst. Akero Therapeutics [AKRO] - Last Close: $12.27 Newly released drug data is rallying shares of Akero Therapeutics. The biotech company released data from a Phase 2b HARMONY study of its lead drug candidate efruxifermin (EFX) pre-cirrhotic nonalcoholic steatohepatitis (NASH) patients. The drug met its primary endpoint in both evaluated EFX dose groups and produced at least a one-stage improvement in 41% of patients, compared to 20% with placebo. EFX also met its key secondary endpoint, with up to 76% of patients achieving NASH resolution without worsening fibrosis. Shares of AKRO are soaring on the upbeat drug news. It's up 94.5% on active trading volume. My Take: This stock is soaring on this news but I am concerned there is more downside at the current price point than upside. You might be a little late to the party on this one, but you can always wait for a pullback if you're bullish. Comera Life Sciences [CMRA] - Last Close: $1.93 Bullish insider buying is boosting Comera Life Sciences this morning. The preclinical stage life sciences company recently filed a corporate disclosure that revealed bullish, high-volume insider buying among key players at the company. According to an SEC Form 4 filing made available after Monday's close, Director Jame Sherblom purchased 50,000 shares of CMRA, bringing his total position to 371,163 shares. Around the same time, CFO & Exec. VP Michael Campbell acquired 25,000 shares, and CEO/Chairman Jeffrey Hackman added 47,600 shares to his holdings. Investors are taking notice of the bullish insider buys. Shares of CMRA are up 23.8% on active trading volume. My Take: Something big might be brewing at this company. It's not everyday you see the CEO, CFO, and a key director adding hundreds of thousands of dollars in shares to their collective positions. Something big might be brewing at CMRA. Syros Pharmaceuticals [SYRS] - Last Close: $0.7303 Syros Pharma is rallying after a key decisions from regulators. The US Food & Drug Administration has awarded the tiny biotech company an Orphan Drug Designation for its pancreatic cancer treatment. According to an FDA online database, regulators have awarded Syros Pharma an ODD for a drug with the generic name of (S)-7-(dimethylphosphoryl)-3-(2-((6,6-dimethylpiperidin-3-yl)amino) 5-(trifluoromethyl)pyrimidin-4-yl)-1H-indole-6-carbonitrile. The name is quite a mouthful, but that's all we have so far. This story hasn't even hit the newswires yet, but I was able to find it by searching through the FDA's AccessData online database. Orphan Drug Designations give companies access to special benefits such as priority regulator review, consultations with regulators, and more. SYRS is one of today's most active premarket stocks, and it's up 18.2%. My Take: Hard to get a clear picture of the ODD's ultimate impact with the limited info we have at this point. However, there could be more upside in this stock from here. The story is just getting out, so there could be room to run higher when the news goes mainstream. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](